Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
89bio, Inc. (ETNB)
|
Add to portfolio |
|
|
|
| Price: |
$13.43
| | Metrics |
| OS: |
75.5
|
M
| |
-3
|
% ROE
|
| Market cap: |
$1.01
|
B
| |
|
|
|
Net cash:
|
$245
|
M
| |
$3.25
|
per share
|
|
EV:
|
$768
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
($0.06)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 80.8 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 102.2 | 0.0 | 0.0 | 0.0 |
| Gross profit | -21.5 | 0.0 | 0.0 | 0.0 |
| Gross margin | -26.6% | | | |
| Research and development | | 70.3 | 36.2 | 21.3 |
| General and administrative | 21.5 | 19.4 | 13.2 | 5.3 |
| EBIT | 102.2 | -89.7 | -49.4 | -26.6 |
| EBIT margin | 126.6% | | | |
| Pre-tax income | 102.0 | -90.3 | -49.6 | -57.2 |
| Income taxes | 0.0 | -0.1 | -0.1 | 0.2 |
| Tax rate | | 0.2% | 0.1% | |
| Net income | 102.0 | -90.1 | -49.5 | -57.4 |
| Net margin | 126.3% | | | |
| |
| Diluted EPS | $2.93 | ($4.48) | ($3.08) | ($24.49) |
| Shares outstanding (diluted) | 34.8 | 20.1 | 16.1 | 2.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|